These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 29773067)

  • 1.
    Sever B; Kucukoglu K; Nadaroglu H; Altıntop MD
    Curr Comput Aided Drug Des; 2019; 15(2):136-144. PubMed ID: 29773067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Some coumarins and benzoxazinones as potent paraoxonase 1 inhibitors.
    Karataş MO; Uslu H; Alıcı B; Gökçe B; Gencer N; Arslan O
    J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1386-91. PubMed ID: 26887799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Some indazoles reduced the activity of human serum paraoxonase 1, an antioxidant enzyme:
    Alım Z; Kılıç D; Demir Y
    Arch Physiol Biochem; 2019 Dec; 125(5):387-395. PubMed ID: 29741961
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis and Evaluation of New 1,3,4-Thiadiazole Derivatives as Potent Antifungal Agents.
    Karaburun AÇ; Acar Çevik U; Osmaniye D; Sağlık BN; Kaya Çavuşoğlu B; Levent S; Özkay Y; Koparal AS; Behçet M; Kaplancıklı ZA
    Molecules; 2018 Nov; 23(12):. PubMed ID: 30501053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological evaluation and in silico study of benzohydrazide derivatives as paraoxonase 1 inhibitors.
    Korkmaz IN; Türkeş C; Demir Y; Öztekin A; Özdemir H; Beydemir Ş
    J Biochem Mol Toxicol; 2022 Nov; 36(11):e23180. PubMed ID: 35916346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naphthoquinones, benzoquinones, and anthraquinones: Molecular docking, ADME and inhibition studies on human serum paraoxonase-1 associated with cardiovascular diseases.
    Demir Y
    Drug Dev Res; 2020 Aug; 81(5):628-636. PubMed ID: 32232985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some calcium-channel blockers: kinetic and
    Türkeş C; Demir Y; Beydemir Ş
    J Biomol Struct Dyn; 2022 Jan; 40(1):77-85. PubMed ID: 32783605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro inhibition effect of some dihydroxy coumarin compounds on purified human serum paraoxonase 1 (PON1).
    Erzengin M; Basaran I; Cakir U; Aybey A; Sinan S
    Appl Biochem Biotechnol; 2012 Nov; 168(6):1540-8. PubMed ID: 22971832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential inhibitors of human carbonic anhydrase isozymes I and II: Design, synthesis and docking studies of new 1,3,4-thiadiazole derivatives.
    Altıntop MD; Sever B; Özdemir A; Kucukoglu K; Onem H; Nadaroglu H; Kaplancıklı ZA
    Bioorg Med Chem; 2017 Jul; 25(13):3547-3554. PubMed ID: 28511907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasound Promoted Green Synthesis, Docking Study of Indole Spliced Thiadiazole, α-amino Phosphonates as Anticancer Agents and Antityrosinase Agents.
    Nikalje AG; Gawhane PA; Tiwari SV; Sangshetti JN; Damale MG
    Anticancer Agents Med Chem; 2018; 18(9):1267-1280. PubMed ID: 29667556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methyl benzoate derivatives: in vitro Paraoxonase 1 inhibition and in silico studies.
    Korkmaz IN; Türkeş C; Demir Y; Özdemir H; Beydemir Ş
    J Biochem Mol Toxicol; 2022 Oct; 36(10):e23152. PubMed ID: 35708184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel nucleophiles enhance the human serum paraoxonase 1 (PON1)-mediated detoxication of organophosphates.
    Chambers JE; Chambers HW; Meek EC; Funck KE; Bhavaraju MH; Gwaltney SR; Pringle RB
    Toxicol Sci; 2015 Jan; 143(1):46-53. PubMed ID: 25304213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the inhibitory effects and molecular docking of some sulfonamides on human serum paraoxonase 1.
    Alim Z; Kilic D; Koksal Z; Beydemir S; Ozdemir H
    J Biochem Mol Toxicol; 2017 Oct; 31(10):. PubMed ID: 28665493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular docking studies and biological evaluation of 1,3,4-thiadiazole derivatives bearing Schiff base moieties as tyrosinase inhibitors.
    Tang J; Liu J; Wu F
    Bioorg Chem; 2016 Dec; 69():29-36. PubMed ID: 27669118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bovine paraoxonase 1 activities in serum and distribution in lipoproteins.
    Miyamoto T; Takahashi Y; Oohashi T; Sato K; Oikawa S
    J Vet Med Sci; 2005 Mar; 67(3):243-8. PubMed ID: 15805725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro effects of thirty-eight cardiac drugs on human serum paraoxonase.
    Argan O; Cikrikci K; Uslu H; Gencer N
    Chem Biol Drug Des; 2022 Jul; 100(1):80-89. PubMed ID: 35395139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, in silico and in vitro screening of 1,2,4-thiadiazole analogues as non-peptide inhibitors of beta-secretase.
    Gurjar AS; Andrisano V; Simone AD; Velingkar VS
    Bioorg Chem; 2014 Dec; 57():90-98. PubMed ID: 25303313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotics Used in Patients after Surgery and Effects of Human Serum Paraoxonase-I (PON1) Enzyme Activity.
    Yılmaz A; Dilek E
    Protein Pept Lett; 2019; 26(3):215-220. PubMed ID: 30678610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Silico Appraisal, Synthesis, Antibacterial Screening and DNA Cleavage for 1,2,5-thiadiazole Derivative.
    Mali SN; Sawant S; Chaudhari HK; Mandewale MC
    Curr Comput Aided Drug Des; 2019; 15(5):445-455. PubMed ID: 30727910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low paraoxonase 1 arylesterase activity and high von Willebrand factor levels are associated with severe coronary atherosclerosis in patients with non-diabetic stable coronary artery disease.
    Ding J; Chen Q; Zhuang X; Feng Z; Xu L; Chen F
    Med Sci Monit; 2014 Nov; 20():2421-9. PubMed ID: 25420483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.